Clinical Trials Browser

Phase 1/2 × Leukemia, Lymphocytic, Chronic, B-Cell × ruxolitinib × Clear all

NCT02912754 2017-03-13

Ruxolitinib Combined With Ibrutinib in Chronic Lymphocytic Leukemia Patients

Phase 1/2 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT02015208 2016-09-26

Ruxolitinib in the Treatment of Chronic Lymphocytic Leukemia

Phase 1/2 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell